help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Behl, C.
Right arrow Articles by Holsboer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behl, C.
Right arrow Articles by Holsboer, F.
Endocrinology Vol. 138, No. 1 101-106
Copyright © 1997 by The Endocrine Society


ARTICLES

Glucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro

Christian Behl, Frank Lezoualc’h1, Thorsten Trapp, Martina Widmann, Thomas Skutella2 and Florian Holsboer

Max Planck Institute of Psychiatry, Clinical Institute, Munich, Germany

Address all correspondence and requests for reprints to: Christian Behl Ph.D., Clinical Institute, Department of Neuroendocrinology, Max Planck Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. E-mail: chris{at}mpipsykl.mpg.de

In patients with Alzheimer’s disease, hippocampal cells are among the first neuronal cells of the brain to degenerate. Both rat primary hippocampal neurons and cells of the clonal mouse hippocampal cell line HT22 express endogenous functional glucocorticoid receptors (GRs), as shown by transient transfection of cells with a luciferase reporter plasmid containing GR-responsive elements. The influence of activated GRs on oxidative stress-induced neuronal cell death in vitro was investigated employing these hippocampal model systems. Two oxidative stressors were investigated, the free radical-inducing Alzheimer’s disease-associated amyloid ß-protein, which is toxic to hippocampal neurons, and the excitatory amino acid glutamate, which induces oxidative cell death in HT22 cells via an increase in intracellular peroxides. Cellular viability was assessed with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide test and trypan exclusion staining, followed by microscopical cell counting. Glucocorticoids strongly increased the vulnerability of the hippocampal cells to amyloid ß-protein and glutamate. This increase could be blocked by the specific GR antagonist RU486. Our data suggest that changes in hippocampal GR homeostasis and regulation may render hippocampal neurons more vulnerable to oxidative stress-induced neuronal degeneration.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
C. S. Barr, R. L. Dvoskin, Q. Yuan, R. H. Lipsky, M. Gupte, X. Hu, Z. Zhou, M. L. Schwandt, S. G. Lindell, M. McKee, et al.
CRH Haplotype as a Factor Influencing Cerebrospinal Fluid Levels of Corticotropin-Releasing Hormone, Hypothalamic-Pituitary-Adrenal Axis Activity, Temperament, and Alcohol Consumption in Rhesus Macaques
Arch Gen Psychiatry, August 1, 2008; 65(8): 934 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al.
Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids
J. Neurosci., April 25, 2007; 27(17): 4562 - 4571.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues
Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis
Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. M. de Pablos, R. F. Villaran, S. Arguelles, A. J. Herrera, J. L. Venero, A. Ayala, J. Cano, and A. Machado
Stress Increases Vulnerability to Inflammation in the Rat Prefrontal Cortex
J. Neurosci., May 24, 2006; 26(21): 5709 - 5719.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Xiao, A. Qi, and Y. Chen
Cultured Embryonic Hippocampal Neurons Deficient in Glucocorticoid (GC) Receptor: A Novel Model for Studying Nongenomic Effects of GC in the Neural System
Endocrinology, September 1, 2005; 146(9): 4036 - 4041.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Hoijman, L. Rocha Viegas, M. I. Keller Sarmiento, R. E. Rosenstein, and A. Pecci
Involvement of Bax Protein in the Prevention of Glucocorticoid-Induced Thymocytes Apoptosis by Melatonin
Endocrinology, January 1, 2004; 145(1): 418 - 425.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Cavigelli and M. K. McClintock
Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death
PNAS, December 23, 2003; 100(26): 16131 - 16136.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Perlman
Concern About Fetus and Newborn Committee Statement on Corticosteroid Use
Pediatrics, November 1, 2002; 110(5): 1034 - 1034.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Wang, J. L. Pongrac, and D. B. DeFranco
Glucocorticoid Receptors in Hippocampal Neurons that Do Not Engage Proteasomes Escape from Hormone-Dependent Down-Regulation but Maintain Transactivation Activity
Mol. Endocrinol., September 1, 2002; 16(9): 1987 - 1998.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA
Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation
FASEB J, June 1, 2002; 16(8): 761 - 770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. J. Lucassen, M. B. Muller, F. Holsboer, J. Bauer, A. Holtrop, J. Wouda, W. J. G. Hoogendijk, E. R. De Kloet, and D. F. Swaab
Hippocampal Apoptosis in Major Depression Is a Minor Event and Absent from Subareas at Risk for Glucocorticoid Overexposure
Am. J. Pathol., February 1, 2001; 158(2): 453 - 468.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 8, 2000; (2000) 260501697.
[Abstract] [Full Text]


Home page
StrokeHome page
H. J. Krugers, S. Maslam, J. Korf, M. Joels, and F. Holsboer
The Corticosterone Synthesis Inhibitor Metyrapone Prevents Hypoxia/Ischemia-Induced Loss of Synaptic Function in the Rat Hippocampus Editorial Comment
Stroke, May 1, 2000; 31(5): 1162 - 1172.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. R. A. Mackenzie
Anti-inflammatory drugs and Alzheimer-type pathology in aging
Neurology, February 8, 2000; 54(3): 732 - 732.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Cardounel, W. Regelson, and M. Kalimi
Dehydroepiandrosterone Protects Hippocampal Neurons Against Neurotoxin-Induced Cell Death: Mechanism of Action
Experimental Biology and Medicine, November 1, 1999; 222(2): 145 - 149.
[Abstract] [Full Text]


Home page
FASEB J.Home page
R. M. ASAINZ, J. C. MAYO, R. J. REITER, I. ANTOLÍN, M. M. ESTEBAN, and C. RODRÍGUEZ
Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus
FASEB J, September 1, 1999; 13(12): 1547 - 1556.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Heck, F. Lezoualc'h, S. Engert, and C. Behl
Insulin-like Growth Factor-1-mediated Neuroprotection against Oxidative Stress Is Associated with Activation of Nuclear Factor kappa B
J. Biol. Chem., April 2, 1999; 274(14): 9828 - 9835.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Lezoualc'h, Y. Sagara, F. Holsboer, and C. Behl
High Constitutive NF-kappa B Activity Mediates Resistance to Oxidative Stress in Neuronal Cells
J. Neurosci., May 1, 1998; 18(9): 3224 - 3232.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Poletti, P. Negri-Cesi, M. Rabuffetti, A. Colciago, F. Celotti, and L. Martini
Transient Expression of the 5{alpha}-Reductase Type 2 Isozyme in the Rat Brain in Late Fetal and Early Postnatal Life
Endocrinology, April 1, 1998; 139(4): 2171 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Ahlbom, V. Gogvadze, M. Chen, G. Celsi, and S. Ceccatelli
Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
PNAS, December 19, 2000; 97(26): 14726 - 14730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society